APA (7th ed.) Citation

Lu, Y., Wu, H., Zhu, T., Li, X., Zuo, J., Hasan, A. A., . . . Hocher, B. (2022). Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy. Biomedicine & pharmacotherapy, 156, . https://doi.org/10.1016/j.biopha.2022.113947

Chicago Style (17th ed.) Citation

Lu, YongPing, et al. "Empagliflozin Reduces Kidney Fibrosis and Improves Kidney Function by Alternative Macrophage Activation in Rats with 5/6-nephrectomy." Biomedicine & Pharmacotherapy 156 (2022). https://doi.org/10.1016/j.biopha.2022.113947.

MLA (9th ed.) Citation

Lu, YongPing, et al. "Empagliflozin Reduces Kidney Fibrosis and Improves Kidney Function by Alternative Macrophage Activation in Rats with 5/6-nephrectomy." Biomedicine & Pharmacotherapy, vol. 156, 2022, https://doi.org/10.1016/j.biopha.2022.113947.